Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Elutia Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 3.23M | 3.29M | +50.7K (+1.6%) |
| Value | $19.8M | $19.4M | −$411.0K (−2.1%) |
New holders (2)
Institutions that held Elutia Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 24,900 | $148.0K | 0.00% |
| Barclays PLC | 3,029 | $18.0K | 0.00% |
Sold out (0)
Institutions that held Elutia Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
None.